Results 91 to 100 of about 995 (171)
Background The use of parallel dynamic tests to identify insulin dysregulation (ID) and pituitary pars intermedia dysfunction (PPID) in horses could have better diagnostic utility than measuring baseline hormone concentrations, if the tests do not alter ...
Elizabeth Hodge +7 more
doaj +1 more source
Background: In dogs, spontaneous Cushing’s syndrome is most often pituitary-dependent and caused by hypersecretion of adrenocorticotropic hormone (ACTH), resulting in increased adrenocortical glucocorticoid secretion similar to horses.
Tera Pijnacker +5 more
doaj +1 more source
EQUINE PITUITARY PARS INTERMEDIA DYSFUNCTION (PPID): PATHOPHYSIOLOGY AND A SURGICAL APPROACH TO TREATMENT [PDF]
Equine pituitary pars intermedia dysfunction (PPID) is a common endocrine disease of the older horse. First described in 1932, and likened to human Cushing’s disease, it is associated with an enlargement of the pituitary gland that was classically termed
Carmalt, James L 1973-
core
Abstract OBJECTIVE To compare tear cortisol concentrations between horses and ponies with pituitary pars intermedia dysfunction (PPID) and healthy nonaged (≤ 15 years old) and aged (≥ 20 years old) horses and to determine whether serum and tear cortisol concentrations were correlated. ANIMALS 11 horses and ponies with PPID and 20 healthy control horses
Kelsey A, Hart +4 more
openaire +2 more sources
Abstract Objective—To determine effects of age and pituitary pars intermedia dysfunction (PPID) on corneal sensitivity in horses. Animals—20 adult horses allocated into 3 groups (PPID group, old [> 15 years old] horses with PPID [n = 5]; old group, old [> 15 years old] horses without PPID [9]; and young group, young [≤ 10 years old] horses ...
Chelsey, Miller +2 more
openaire +2 more sources
Metabolic and Endocrine Insights in Donkeys
Donkey medicine is gaining attention due to their increased use as companion animals, in shows, asinotherapy, etc. The increasing demand and unique aspects call for specialized care, requiring new information (physiology, infectious disorders ...
Francisco J. Mendoza +2 more
doaj +1 more source
Ertugliflozin is a sodium-glucose co-transporter-2 inhibitor that has demonstrated promise as a treatment for hyperinsulinaemia in horses. Despite the frequent use of ertugliflozin in equine clinical practice, the pharmacokinetics of this drug in horses ...
Naomi C. Kirkwood +5 more
doaj +1 more source
Pituitary pars intermedia dysfunction (PPID), vroeger vooral bekend onder de naam 'Cushing's disease' is een veel voorkomende aandoening bij oudere paarden.
Broux, Barbara +2 more
core
Immunoreactive insulin stability in horses at risk of insulin dysregulation
Background Diseases associated with insulin dysregulation (ID), such as equine metabolic syndrome and pituitary pars intermedia dysfunction, are of interest to practitioners because of their association with laminitis.
Dakota H. Leschke +5 more
doaj +1 more source
Background: Glucocorticoids are suggested to precipitate laminitis and induce insulin resistance in horses. Hypothesis/Objectives: To assess insulin sensitivity and the basal amount of glucose metabolized in equine pituitary pars intermedia dysfunction ...
Paul P.C.A. Menheere +5 more
core +1 more source

